Prothena Corporation plc: Prothena Reports Third Quarter 2021 Financial Results and Business Highlights

Net cash provided by operating and investing activities was $111.9 million in the third quarter and $114.8 million for the first nine months of 2021; Quarter-end cash and restricted cash position was $601.5

Related Keywords

Ireland ,Dublin ,Brandon Smith ,Jennifer Zibuda ,Tran Nguyen ,Piper Sandler ,Bristol Meyer Squibb ,Alzheimer Association International Conference ,Investor Relations Communications ,Nasdaq ,Company On Twitter Prothenacorp ,Exchange Commission ,Bristol Myers Squibb ,Novo Nordisk ,Prothena Corporation ,Bristol Myers ,Mayo Stage ,Gene Kinney ,Chief Executive Officer ,Recent Business Highlights ,Association International ,Financial Officer Tran Nguyen ,Chief Strategy Officer ,Chief Operating ,Upcoming Milestones ,New Drug Application ,Healthcare Conference ,London Healthcare Conference ,Annual Healthcare Conference ,First Nine Months ,Quarterly Report ,Investor Relations ,Prothena ,Corporation ,Reports ,Third ,Quarter ,021 ,Financial ,Results ,Business ,Highlights ,